JOHNSON & JOHNSON (JNJ)
2025-06-29 | 2025-03-30 | 2024-09-29 | 2024-06-30 | |
|---|---|---|---|---|
| Sales to customers (note 9) | 23,743 | 21,893 | 22,471 | 22,447 |
| Cost of products sold | 7,628 | 7,357 | 6,963 | 6,869 |
| Gross profit | 16,115 | 14,536 | 15,508 | 15,578 |
| In-process research and development impairments | - | - | - | 194 |
| Interest expense, net of portion capitalized | 308 | 204 | 193 | 270 |
| Interest income | 260 | 332 | 292 | 395 |
| Other (income) expense, net | -107 | 7,321 | -1,798 | -653 |
| Research and development expense | 3,516 | 3,225 | 4,952 | 3,440 |
| Restructuring (note 12) | 64 | 17 | 41 | -13 |
| Selling, marketing and administrative expenses | 5,889 | 5,112 | 5,478 | 5,681 |
| Earnings before provision for taxes on income | 6,491 | 13,631 | 3,338 | 5,748 |
| Provision for taxes on income (note5) | 954 | 2,632 | 644 | 1,062 |
| Net earnings from continuing operations | - | - | 2,694 | 4,686 |
| Net earnings from discontinued operations, net of tax (note 13) | - | - | - | - |
| Net earnings | 5,537 | 10,999 | 2,694 | 4,686 |
| Basic (shares) | 2,406,300,000 | 2,407,200,000 | 2,407,200,000 | 2,406,800,000 |
| Diluted (shares) | 2,419,100,000 | 2,423,800,000 | 2,427,900,000 | 2,422,000,000 |
| Total net earnings per share - basic (in dollars per share) | 2.3 | 4.57 | 1.12 | 1.95 |
| Total net earnings per share - diluted (in dollars per share) | 2.29 | 4.54 | 1.11 | 1.93 |